24
Participants
Start Date
May 15, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
RJMty19 (CD19-CAR-DNT cells)
Lentiviral vector-transducted double negative T cells (DNT) to express anti-CD19 CAR. Prior to cellular infusion, each patient received cyclophosphamide and fludarabine lymphodepleting chemotherapy.
Peking University People's Hospital, Beijing
Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai
Changhai Hospital, Shanghai
Nanjing Drum Tower Hospital, Nanjing
RenJi Hospital
OTHER
Peking University People's Hospital
OTHER
Changhai Hospital
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
Guangdong Ruishun Biotech Co., Ltd
INDUSTRY